Journal article
Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation Carriers
Abstract
BACKGROUND: Hormone therapy (HT) is commonly given to women to alleviate the climacteric symptoms associated with menopause. There is concern that this treatment may increase the risk of breast cancer. The potential association of HT and breast cancer risk is of particular interest to women who carry a mutation in BRCA1 because they face a high lifetime risk of breast cancer and because many of these women take HT after undergoing prophylactic …
Authors
Eisen A; Lubinski J; Gronwald J; Moller P; Lynch HT; Klijn J; Kim-Sing C; Neuhausen SL; Gilbert L; Ghadirian P
Journal
Journal of the National Cancer Institute, Vol. 100, No. 19, pp. 1361–1367
Publisher
Oxford University Press (OUP)
Publication Date
October 1, 2008
DOI
10.1093/jnci/djn313
ISSN
0027-8874